Showing results (21-30 of 94) with videos related to
Sort By:
Pageof 10
Molecular Medicine Reports|December 9, 2014
Smad4 suppresses the progression of renal cell carcinoma via the activation of forkhead box protein H1Yunli Liu, Yangyang Xu, Xuedong Li, et al.Scientific Reports|August 27, 2023
Prophylactic use amphotericin B use in patients with hematologic disorders complicated by neutropenia: a systematic review and meta-analysisZhaoyan Chen, Qiyi Feng, Xiaoxing Wang, et al.Frontiers in Pharmacology|August 4, 2022
Increasing Trends of Polypharmacy and Potentially Inappropriate Medication Use in Older Lung Cancer Patients in China: A Repeated Cross-Sectional StudyFangyuan Tian, Zhaoyan Chen, Xi Chen, et al.Frontiers in Pharmacology|January 2, 2023
Prevalence of polypharmacy and potentially inappropriate medication use in older lung cancer patients: A systematic review and meta-analysisFangyuan Tian, Zhaoyan Chen, Dan Zhou, et al.Zhonghua Wei Zhong Bing Ji Jiu Yi Xue|July 23, 2021
[Research progress on the mechanism of two-component systems in regulating carbapenem resistance of Klebsiella pneumoniae]Zhaoyan Chen, Zhidan Qin, Liangyan Jiang, et al.Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|April 12, 2020
Antiproliferative activities of auraptenol against drug-resistant human prostate carcinoma cells are mediated via programmed cell death, endogenous ROS production, and targeting the JNK/p38 MAPK signal pathwaysYunli Liu, Xuedong Li, Zhaoyan Chen, et al.Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|July 16, 2021
Antiproliferative activities of auraptenol against drug-resistant human prostate carcinoma cells are mediated via programmed cell death, endogenous ROS production, and targeting the JNK/p38 MAPK signal pathwaysYunli Liu, Xuedong Li, Zhaoyan Chen, et al.Frontiers in Pharmacology|May 2, 2022
Prescription of Potentially Inappropriate Medication Use in Older Cancer Outpatients With Multimorbidity: Concordance Among the Chinese, AGS/Beers, and STOPP CriteriaFangyuan Tian, Mengnan Zhao, Zhaoyan Chen, et al.Journal of Global Health|June 19, 2025
Trends of potentially inappropriate prescribing among older outpatients in China between 2015-21Fangyuan Tian, Zhaoyan Chen, Ying Zhang, et al.Oncology Letters|January 4, 2020
Cost-effectiveness analysis of the addition of bevacizumab to temozolomide therapy for the treatment of unresected glioblastomaZhaoyan Chen, Mei Zhan, Fangyuan Tian, et al.Pageof 10